Barbara Oil Co’s Accelerate Diagnostics AXDX Stock Holding History

Barbara Oil Co’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-900	Closed	-$207K	–	84
2018 Q3	$207K	Hold	900	–	–	0.12%	85
2018 Q2	$201K	Hold	900	–	–	0.13%	85
2018 Q1	$206K	Hold	900	–	–	0.13%	85
2017 Q4	$236K	Hold	900	–	–	0.15%	86
2017 Q3	$202K	Hold	900	–	–	0.14%	85
2017 Q2	$246K	Hold	900	–	–	0.18%	83
2017 Q1	$218K	Buy	+900	New	+$206K	0.16%	84

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

CAM

Close Asset Management London, United Kingdom $3.76B AUM 40.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barbara Oil Co's AXDX Position: Q4 2018 in Review

Barbara Oil Co sold out of Accelerate Diagnostics (AXDX) in Q4 2018, closing a stake of 900 shares — an estimated $207K sold.

Barbara Oil Co first reported a position in AXDX in Q1 2017 and held it in 7 quarters. The position peaked at $246K in Q2 2017. 107 funds tracked by Wall St. Rank hold AXDX as of Q4 2018.

Barbara Oil Co reported no remaining Accelerate Diagnostics position as of Q4 2018 after selling out during the quarter.
Barbara Oil Co sold 900 Accelerate Diagnostics shares in Q4 2018, an estimated $207K.
Barbara Oil Co first reported a position in Accelerate Diagnostics in Q1 2017 and held it in 7 quarters.
Barbara Oil Co's Accelerate Diagnostics position peaked at $246K in Q2 2017.
107 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2018.

Based on Barbara Oil Co's 13F filing for Q4 2018, filed 7 Feb 2019.